HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Takami Miki Selected Research

Oncogenic osteomalacia

1/2012Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia.
10/2011Evaluation of bone markers in hypophosphatemic rickets/osteomalacia.
6/2010The levels of somatostatin receptors in causative tumors of oncogenic osteomalacia are insufficient for their agonist to normalize serum phosphate levels.
4/2006Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Takami Miki Research Topics

Disease

16Osteoporosis
01/2015 - 01/2002
13Chronic Kidney Failure (Chronic Renal Failure)
01/2006 - 01/2002
8Alzheimer Disease (Alzheimer's Disease)
07/2014 - 11/2004
7Bone Resorption
04/2007 - 01/2002
6Parkinson Disease (Parkinson's Disease)
09/2011 - 01/2010
5Primary Hyperparathyroidism
07/2011 - 10/2005
5Diabetes Mellitus
06/2010 - 12/2002
4Secondary Hyperparathyroidism
07/2011 - 10/2005
4Cardiovascular Diseases (Cardiovascular Disease)
09/2005 - 12/2002
4Renal Insufficiency (Renal Failure)
09/2004 - 05/2003
4Atherosclerosis
08/2003 - 01/2002
3Dementia (Dementias)
02/2012 - 09/2011
3Neoplasms (Cancer)
01/2012 - 01/2006
3Osteomalacia
01/2012 - 01/2004
3Uremia
01/2006 - 03/2004
3Insulin Resistance
09/2004 - 07/2002
2Rare Diseases (Rare Disease)
01/2012 - 06/2010
2Hypophosphatemia
10/2011 - 06/2010
2X-Linked Dominant Hypophosphatemic Rickets (X-Linked Hypophosphatemia)
10/2011 - 04/2006
2Hyperparathyroidism
07/2011 - 10/2005
2Hypertension (High Blood Pressure)
06/2010 - 09/2004
2Hypercalcemia (Milk Alkali Syndrome)
10/2005 - 09/2005
2Postmenopausal Osteoporosis
01/2004 - 01/2003
1Pain (Aches)
09/2015
1Osteitis Deformans (Paget's Disease of Bone)
09/2015
1Bone Fractures (Bone Fracture)
01/2015
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
09/2014
1Multiple Sclerosis
05/2014
1Encephalitis (Encephalitis, Rasmussen)
05/2014
1Frontotemporal Dementia
02/2012
1Motor Neuron Disease (Primary Lateral Sclerosis)
02/2012
1Frontotemporal Lobar Degeneration (Semantic Dementia)
01/2012
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2012
1Acute Promyelocytic Leukemia
01/2012
1Memory Disorders (Memory Loss)
01/2012
1Neurodegenerative Diseases (Neurodegenerative Disease)
09/2011
1Hyperplasia
07/2011
1Amyloid Plaque
01/2011
1Atrophy
01/2011
1Hypercholesterolemia
06/2010

Drug/Important Bio-Agent (IBA)

8Parathyroid Hormone (Parathormone)IBA
01/2010 - 10/2002
6Biological Markers (Surrogate Marker)IBA
01/2013 - 01/2004
4fibroblast growth factor 23IBA
01/2012 - 01/2006
4Oncogenic osteomalaciaIBA
01/2012 - 04/2006
4Insulin (Novolin)FDA Link
05/2010 - 07/2002
4HDL CholesterolIBA
03/2005 - 03/2003
4Lipoproteins (Lipoprotein)IBA
09/2004 - 01/2002
3Amyloid (Amyloid Fibrils)IBA
07/2014 - 01/2011
32- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
02/2012 - 09/2011
3cinacalcet (Sensipar)FDA Link
07/2011 - 10/2005
3Cyclin D1IBA
07/2011 - 10/2005
31-hydroxycholecalciferol (alfacalcidol)IBA
01/2010 - 01/2002
3Cholecalciferol (Vitamin D3)FDA Link
01/2010 - 01/2002
3CreatinineIBA
01/2006 - 05/2003
3CalciumIBA
01/2006 - 01/2002
3deoxypyridinolineIBA
02/2005 - 10/2002
2bazedoxifene acetateIBA
01/2015 - 03/2011
2Raloxifene (Evista)FDA Link
09/2010 - 01/2006
2Calcium-Sensing ReceptorsIBA
01/2006 - 10/2005
2pyridinolineIBA
02/2005 - 10/2002
2collagen type I trimeric cross-linked peptideIBA
02/2005 - 01/2004
2OsteocalcinIBA
02/2005 - 01/2003
2Etidronic Acid (HEDP)FDA LinkGeneric
01/2004 - 01/2003
2glutamyl- lysyl- alanyl- histidyl- aspartyl- glycyl- glycyl- arginineIBA
01/2004 - 10/2002
2Serum AlbuminIBA
05/2003 - 05/2003
2oxidized low density lipoproteinIBA
05/2003 - 12/2002
2C-Reactive ProteinIBA
05/2003 - 12/2002
1ruberythric acid (AlP)IBA
09/2015
1risedronic acid (risedronate)FDA LinkGeneric
09/2015
1Vitamin DFDA LinkGeneric
09/2014
1denosumabFDA Link
07/2014
1N-Methylaspartate (NMDA)IBA
05/2014
1Messenger RNA (mRNA)IBA
01/2012
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
01/2012
1Scopolamine (Hyoscine)FDA Link
01/2012
1CytokinesIBA
01/2012
1Am 80 (tamibarotene)IBA
01/2012
1Apolipoproteins E (ApoE)IBA
09/2011
1Cytochrome P-450 CYP2E1 (CYP2E1)IBA
09/2011
1IronIBA
07/2011
1CopperIBA
07/2011
1ZincIBA
07/2011
1CoffeeFDA Link
07/2011
1HormonesIBA
07/2011
1Caffeine (No Doz)FDA LinkGeneric
07/2011
1HomocysteineIBA
09/2010
1Folic Acid (Vitamin M)FDA LinkGeneric
09/2010
1Vitamin B 6IBA
09/2010
1Vitamin B Complex (B Vitamins)IBA
09/2010
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
09/2010
1Riboflavin (Vitamin B2)FDA LinkGeneric
09/2010
1ORALIT (ORS)IBA
06/2010
1somatostatin receptor type 1IBA
06/2010
1Octreotide (Sandostatin)FDA LinkGeneric
06/2010
1Somatostatin Receptors (Somatostatin Receptor)IBA
06/2010
1somatostatin receptor 2IBA
06/2010
1Dopamine (Intropin)FDA LinkGeneric
05/2010
1CarbohydratesIBA
05/2010
1Dietary Fats (Ghee)IBA
01/2010

Therapy/Procedure

9Renal Dialysis (Hemodialysis)
09/2005 - 07/2002